GSK Plugs Into Bioelectronics With $50 Million Venture Fund by Ben Hirschler. Reuters. August 8, 2013.
(1) Bioelectronics or electroceuticals uses _______________ rather than chemicals or biological molecules to treat conditions.
(2) GSK is first investing in SetPoint which is developing a new set of therapies for ___________________.
(3) The bioelectronic approach to these conditions uses an _____________ to stimulate the _____________ to produce an anti-inflammatory effect.
(4) Possible future applications include ________________________________.
No comments:
Post a Comment